In 304 patients randomised after radical nephroureterectomy for upper tract urothelial carcinoma, a single early intravesical pirarubicin instillation improved 3-year relapse-free survival vs observation (60.0% vs 47.0%; HR 0.67); grade 3-4 haematuria in 3%.
RCTn = 304
Ito et al. Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial